Skip to main content

New R&D base for James Robinson

James Robinson Speciality Ingredients (JRSI) has launched a dedicated 186 m2 biotechnology R&D facility in Manchester. The Biotome division “will significantly extend the company’s research capabilities and production capacity, as it looks to explore more sustainable biotechnology ingredients”, JRSI said.

CEFIC releases CSS impact report

CEFIC has released the first in a series of studies about the likely impact of the EU Chemicals Strategy for Sustainability (CSS). It subsequently joined other industry leaders in calling on European Commission and EU Member State governments “to work together to develop an EU Chemical Industry Transition Pathway to sustain the massive investments required to meet the objectives of the EU Green Deal”.

Ascensus buys Wychem

Ascensus Specialties, a provider of speciality materials for life sciences and advanced technology, has followed up on previous acquisitions by buying fine chemicals manufacturer Wychem from private equity firm Aurelius, which had acquired it in 2016. The company employs 25 people at its site in the UK.

Feature article - Recent R&D developments for biosolutions in agriculture

Karan Chechi of ChemAnalyst looks at why demand is growing for a key alternative to agrochemicals

Agrochemicals such as pesticides, fertilisers and plant growth enhancers have played a crucial role over the last century. They allowed agricultural productivity to keep up with population growth and saved billions from starvation.

Draslovka: One done, one denied

Draslovka, a specialist in cyanide chemistry based in the Czech Republic, has completed the previously announced acquisition of Chemours’s Mining Solutions business for $521 million. However, its proposed acquisition of Sasol’s sodium cyanide business has been blocked by the South African competition authorities.

Umicore, VW in battery materials JV

Subject to final agreements and customary conditions, including regulatory approvals, Umicore and Volkswagen will establish a joint venture in precursor and cathode material production in Europe. This will begin in 2025 with initial production of 20 GWh/year for the plant in Salzgitter, Germany, and should grow to 160 GWh/year by 2030, enough to power about 2.2 million full electric vehicles.

Inovyn launches bio-attributed epichlorohydrin

Ineos subsidiary Inovyn has become the world’s first commercial producer of bio-attributed epichlorohydrin from renewable feedstock. Branded Reodrin, this is made at a site in Tavaux, France. Applications are expected in sectors including composites for wind turbines, wastewater treatment and lightweight coatings for electric vehicles.

Subscribe to Current issue